Bloomberg News

Three to Watch: BMY, QSFT, AOL

June 25, 2012

The FDA does not approve Bristol Meyers' pill Eliquis, Quest gets a new offer and AOL considers share repurchase

Monsanto vs. GMO Haters
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus